Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | MTOR | P42345 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | HBB | P68871 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29762960 | 1.00 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AGMNN | |
| SCHEMBL31685319 | 0.89 | ADORA2A (0.53) | CYP2C19ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL31685809 | 0.86 | ADORA3 (0.62) | CYP2C19LMNANT5EHIF1ATP53 | |
| SCHEMBL31685223 | 0.85 | ADORA1 (0.58) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL31685494 | 0.85 | HPGD (0.57) | CYP2C19LMNANT5EHIF1AGMNN | |
| SCHEMBL31685571 | 0.85 | CA5A (0.67) | NT5EADORA1 | |
| SCHEMBL62505 | 0.84 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL343478 | 0.84 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL14931005 | 0.84 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A | |
| SCHEMBL18512921 | 0.84 | CYP2C19 (0.62) | CYP2C19LMNANT5EHIF1AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070027164-A1 | Agents for treating neurodegenerative diseases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027164-A1 | Agents for treating neurodegenerative diseases | HTT, NLN, CLN6 | CYP2C19 4879/4885LMNA 1866/4885NT5E 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.